Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating arsenic trioxide in combination with fluorouracil and leucovorin for patients with stage IV colorectal cancer that relapsed or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arsenic Trioxide (arsenic trioxide)
  • FLUOROURACIL (Fluorouracil)
  • Leucovorin (folinic acid)

Snippet

Sponsor: University of Miami | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED